PCSK9 levels were also significantly higher in untreated HoFH patients (279±27 ng/mL) and untreated HeFH patients (202±14 ng/mL) compared with control subjects (132±10 ng/mL) (both P<0.01). Here, PCSK9 is linked to homozygous familial hypercholesterolemia.